<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 153 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page152.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=153">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 153 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 153</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=153"><img src="../thumb/153.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>122 / 2020-04                                                   Cardio-Vascular Agents - 7.3.9 / 7.3.10

              THE NOAC* YOU AND YOUR PATIENTS CAN RELY ON


                *NOAC = non-vitamin K oral anticoagulant

   with NSAIDs, inhibits.of uptake transporter (rifampicin, ciclosporin)/   assessm. dur. eval. of HF pts., lact.intol., dual block.of RAAS with con-  Indications: Mild to mod.hypertens.
   efflux transporter (ritonavir) incr. system.valsart.expos.  com. ARB’s/ACE inhib./aliskiren incr.risk of hypotens./ hyperkalaem.&   (S3) TABS. 43/7.1.3/0036, 0037
   VALHEFT, (Forrester) LeBasi [P/S]  decr.ren.funct., adeq. hydrat./ren.funct.monit.with concom.NSAID  715555-001: 80 mg, 28, R129,18
                                Interactions: High.freq.of adv.events with concom. ACE inhib./
                                                              715556-001: 160 mg, 28, R129,18
   Valsartan                    ARBs/aliskiren, poss.incr.ser. K with K  spar.diurets./K  supplem./  Dosage: Recomm.dos: 80 mg or 160 mg once dly. Substant. eff.
                                             +
                                                 +
                                                       +
   Indications: Mild to mod.hypertens., heart fail. (NYHA class II-IV)  salt substit.& incr. ser. creatin.lev.in HF, reduc.Li clear., antihyper-  pres.within 2 wks.& max. eff.aft. 4 wks. May be incr.to 320 mg dly.
   (S3) TABS. 46/7.1.3/0744, 0745  tens. eff.potent.by meds./agents low.BP, incr. mortalit.in HF pts.with
   3000480-001: 80 mg, 30, R108,98  concom.ACE inhib.& beta-blocks., NSAID reduc.antihypertens.eff.  or add diuret.in pts.not adeq.control. May be admin.with other anti-
                                                              hypertens.agents.
   3000481-001: 160 mg, 30, R108,98
   Dosage: Admin.without crush./chew.  ZARTAN, Pharma Dynamics [P/S]  Contraindications: Pregn., lactat., angioed. relat. to prev.ACE in-
                                                              hibit/ARB ther., Li ther., safety & effic.in childr.not est., safety in por-
   Hypertens: Recomm.dos: 80 mg or 160 mg once dly. Substant.  Losartan.  phyr. not est., heredit./idiopath.angioed., hypertroph. obstruct. car-
   eff.pres.within 2 wks.& max.eff.aft. 4 wks. May be incr.to 320 mg   Indications: Hypertens.
   dly.or add diuret.in pts. not adeq.control. May be admin.with other   (S3) TABS, 41/7.1.3/0287, 0289  diomyopathy, mod.to sev.ren. impairm., bil.ren.artery stenos., ren.
                                                              artery stenos. with sngl.kidn., aort.stenos., concom.K spar. diuret.
                                                                                    +
   anti-hypertens.agents.       709225-001: 50 mg, 30, R100,16
   Heart fail: Recomm.dos: 40 mg 2x dly. Up-titrat. to 80 mg & 160 mg   709964-001: 100 mg, 30, R90,90  Side effects: Hypotens., vir.infects., URTI, pharyngit., sinusit., rhinit.,
   2xdly to high.dos.tol. Dos. reduct. of concom.diurets.may be consid.   Dosage: Init & maint dos: 50 mg once dly. Max.eff.attain. 3-6 wks.  neutropen., thrombocytopen., hypersens.incl.ser.sickn., hyperkalaem.,
   Max 320 mg dly.in div.dos.   aft.initiat. May be incr.to 100 mg once dly. May be admin.with other   insomn., decr.libido, syncope, dizzin., headache, vertigo, card.fail.,
   Contraindications: Pregn., safety in lactat.not est., sev.ren.funct.  antihypertens.  vasculit., cough, GI disturbs., angioneurot.oed., rash, prurit., Henoch
   impairm.(creatin.clear.less than 30 ml/ min.), angioed.hist.relat.to   Contraindications: Pregn., lactat., safety & effic.in childr.not est.  Schonlein purpura, psorias., back pain, arthralg., myalg., ren.impairm.,
   prev.ACE-inhibit./ ARB ther., heredit./idiopath.angioed, hypertroph.   Side effects: Symptomat.hypotens.,angioed., GI disturbs., taste   ac.ren.fail., fatig., asthen., oed., elev.LFT.
   obstruct.cardiomyopathy, bil.ren.art./ aort. stenos., ren.art.stenos.  disturbs./loss thereof, urticar., rash, atypic.cutan.lymphoid infiltrat.,   Special precautions: Na & vol.deplet.theref. correct. bef.init.
              +
   with sngl.kidn., concom. K  spar.diuret./K supplem./K cont. substit.,   palpitat., tachycard., back & leg pain, musc.cramps, myalg., headache,   ther., incr.mortalit.in HF pts. receiv. ACE inhibit./beta-block.theref.not
                    +
                         +
   porphyr., Li ther., concom.aliskiren-contain. prods., sev.liv.impairm./  insomn., migraine, cough, nas. congest., pharyngit., sinus disords.,   recomm., monit.bld.urea & serum creatinine in pts. with bilat.& unilat.
                                                                           -
   bil.obstruct./ cholestasis.  URTI, cholestas., symptomat.anaem., decr.Hb, ac. pancreatit., abdom.  ren.artery stenos., monit. ser. K in elderly/ren.impairm.& concom.K- -
   Side effects: Freq: Vir.infects., neutropen., postur. dizzin., postur./  pain, asthen., chest pain, fatig., oed., imp.ren.funct., hyperkalaem.  spar. diuret., bil.-obstruct.disords., hepat.impairm. hist., incr.mortalit.
   orthostat.hypotens. Less freq: URTI, pharyngit./sinusit, rhinit., throm-  Special precautions: Adeq.contracept.for women of childbear.  report.in HF pts.on concom. ACE inhibit./beta-block.& Zomevek.
   bocytopen., hypersens.incl.ser.sickn., angioed., hyperkalaem., insomn,   age, bilat./sngl.ren.artery stenos., aort.valve stenos., hypertroph.  Drug interactions: Antihypertens.eff.antagon by NSAID’s, sym-
                                                                                        -
   decr.libido, dizzin., syncope, headache, blurr.vis., vertigo, card. fail.,   obstruct. cardiomyopathy, hepat./ren.impairm., vol.deplet., elderly,   pathomimet.reduc. antihypertens. eff., incr.ser.K+ lev with K sup-
                                                                  -
                                     +
   hypotens., vasculit., cough, diarrh., abdom. pain, naus., prurit., rash,   monit.ser.K  conc., where ren.funct. depend. on renin-angiotensin-  plem. or Ksalt substit.
   urticar., back pain, arthralg./ myalg., rhabdomyolys., ac.ren.fail., ren.   aldoster.syst.eg. sev.CHF.
   impairm,/-insuffic., fatig., asthen., oed., elev.liv. enzym., decr.haema-  Drug interactions: NSAID’s may antagon.eff., sympathomim.
                                                  +
                                                        +
   tocrit./haemoglob./WBC, incr. ser.creatin./bilirub/potass. Unknown   may reduc.eff., poss.hyperkalaem. with K -spar.diuret./K -contain.
                                     +
   freq: Hepatit., alopec.      meds.or K  supplem.           7.3.10  Others
   Warnings and special precautions: No re-challenge aft.angioed.  ZARTAN CO, Pharma Dynamics
   react., discont.ther.if pregn. susp/ plann., adeq.contracept.in women   Losartan potassium 50(100) mg, hydrochlorothiazide 12,5(25) mg.  CADUET, Pfizer [P/S]
   of child-bear. age, hypotens., Na & vol.deplet.theref. correct. bef.init.  Indications: Hypertens.in pts.est.on identic.dos. of these indiv.ingreds.  Amlodipine besylate, atorvastatin calcium
   ther./admin.low.dos., poss.tox.Li-conc. with concom.Li, ren.funct.  (S3) TABS. A42/7.1.3/1068, 1069  Indications: Incr.CV risk due to concom. hypertens. & dyslipidaem.
   assessm.dur.eval. of HF pts., monit.ser.K lev.esp.in elderly/ren. im-  716216-001: 50/12,5 mg, 30, R99,84  and/or ang.& concom. dyslipidaem.
                    +
   pairm., avoid concom.K spar.diurets., monit.bld. urea/ ser. creatin.in   716217-001: 100/25 mg, 30, R91,50  (S4) TABS. A39/7.0/0326, 0327, 0330, 0331, 0332.
             +
   pts.with ren.art.stenos., hepat. impairm. hist., HF, incr.mortalit.in HF   Dosage: May be admin.with antihypertens.agents Ca chann.  705837-001: 5/10 mg, 30, R308,96
   pts.receiv. Valheft/ACE inhibit./beta-block.concom., HF pts where   block & beta-block.  705838-001: 5/20 mg, 30, R436,17
   ren.funct.depend.on renin-angiotens.-aldost. syst., incr.ren.impairm.  Start.& maint.dos: one 50/12,5 mg tab.dly. If respons. inadeq.dos.may   705835-001: 10/10 mg, 30, R341,51
   risk with concom. NSAIDs partic.in case of inadeq.hydrat,dual block.   be incr.to 100/25 mg once dly. Max.therapeut.eff.attain.within 3 wks.  705836-001: 10/20 mg, 30, R448,81
   of RAAS with ARB’s/ACE inhibit./aliskiren assoc. with high.freq.hy-  Contraindications: Anuria, sulphonamide deriv. meds. hypersens.,   708835-001: 10/40 mg, 30, R542,31
   potens./hyperkalaem.& decr.ren. funct., consid.dos.reduct.in symp-  mod to sev.ren.funct.impairm., hepat. funct.impairm., safety & effic.in   Dosage: Init.& contin.appropr.non pharmacolog. meas.incl.diet/ex-
   tomat.hypotens./ ren.dysfunct., lact./galactose intol, safety & effic.   paed.pts. not est., angioed.hist relat.to prev.ACE/ARB ther., heredit. /  erc.ther.bef.& dur.treatm. Monit. eff.2-4 wks.aft.init.& adjust accord.
   in childr.& adolesc.bel.18 yrs.not est.  idiopath.angioed., hypertroph.obstruct. cardiomyopathy, bil./sngl.ren.  Indiv.start..& maint.dos.on effectiven.& tol.for each indiv.compon.,
   Interactions: Antihypertens.eff.potent.by meds./ agents low.BP/  artery stenos., aort. stenos., concom.K -spar.diuret., porphyr., Addison   may be used eith.alone/in combinat. with oth.anti-hypertens./
                                                +
   NSAID, poss.incr.hyperklaem.eff. with K  spar.diurets./K  supplem./  dis., Li ther., pregn., lactat., Lapp-lact.defic/gluc. galact.malabsorpt.  anti-angin. drugs
                   +
                          +
   other meds. caus. hyperkalaem.  Side effects: Bld.disords., rhabdomyolys., ac. pancreatit., hyper-  Init.ther: Bas.on appropr.combinat.of recommendat. for each com-
   VASOVAN, Unicorn [P/S]       kalaem., hyponatraem., headache, dizzin., asthen., fatig., insomn.,   pon.separtely. Max. amlodipine compon:10 mg once dly & atorvastat.
                                                              compon.80 mg once dly.
   Valsartan                    migraine, palpitat., tachycard., hypotens.incl. orthostat.-/sympto-  Substit.ther: May be substit.for indiv.titrat. compon. Give the equiv.
   Indications: Mild to mod.hypertens., heart fail. (NYHA class II-IV)  mat.hypotens., oed., swell., cough, nas.congest., pharyngit., sinus
   (S3) TABS. A46/7.1.3/0951, 0952  disords., URI, chest pain, abdom.pain, taste disturbs., complete taste   dos.of Caduet or Caduet dos. with incr.amlodipine/atorvastat.or both
                                                              for addit. effs. When init.for one indicat.& continuat. of treatm.of other
   723770-001 80 mg, 28, R98,56  loss, GI disturbs., rais.liv.enzymes, sev. ac. hepatotox., cholestas.,
   723771-001 160 mg, 28, R98,56  hepatit., jaund., skin disords.incl.urticar., rash, atypic.cutan.lymph.   indicat.recomm.start.dos should be select.on continuat.of compon al-
   Dosage: Hypertens: Recomm.dos: 80 mg or 160 mg once dly.   infiltrat., vasculit., musc.cramps, back-/leg-/musc. pain, myalg., imp.  ready being used and recomm.start.dos.of the compon.being added.
   Substant.eff.pres.within 2 wks.& max. eff.aft. 4 wks. May be incr.to   ren.funct., photosens., resp. distress incl.pneumonit.& pulm.oed.,   Prim.hypercholesterolaem.& mix. hyperlipidaem: Maj.pts.
   320 mg dly.or add diuret.in pts.not adeq.control. May be admin. with   anaphylact. reacts., electrol.imbal., hyperuricaem., hyperglycaem.,   control.on 10 mg atorvastatin once dly
   other anti-hypertens.agents.  vertigo, paraesthes., vis.disturbs., xanthopsia, sialadenit., weakn.,   Homozygous familial hypercholesterolaem: Most respond.on
   Heart fail: Recomm.init.dos: 40 mg 2x dly. Up-titrat. to 80 mg &   restlessn., arthralg.  80 mg atorvastatin once dly.
                                Special precautions: Correct Na/vol.deplet.bef. init./admin.low.
   160 mg 2xdly to high.dos.tol. Dos. reduct.of concom.diurets.may be   Contraindications: Hypersens.to dihydropyridines, act.liv.dis.,
   cons. Max. 320 mg dly. in div.dos.   dos., correct electrol.imbal., diab. mellit./hyperglycaem./gout/ hy-  persist.unexpl. elev. ser. transaminas.exceed.3xULN, myopathy,
                                peruricaem. & SLE poss.exacerb., hypersens.more likely in allerg./
   Contraindications: Pregn.& lactat., sev.ren. impairm.(creatin. clear.  pregn., breastfeed., women of childbear.potent.not using appropr.
   less than 30 ml/min.), angioed.hist.relat.to prev. ACE-inhibit./ARB ther.  bronch.asthma pts., dos.adjustm.of antidiabet. agents poss.necess.,   contracept.methods.
                                admin.1 hr.bef. cholestyramine /colestipol, poss.ren.fail.if ren. funct.
   in which case no re-challange aft.angioed.react., heredit./idiopath.  +  Side effects: Amlodipine: Common: Flush., abdom. pain, naus.,
   angioed., hypertroph. obstruct. cardiomyopathy, bil.ren.art.stenos.,   depend. on renin-angiotens.syst.esp.CHF pts., monit.ser.K  esp.in el-  oed., fatig. Uncommon: Insomn., mood changes, trem, taste pervers.,
                                derly & in ren.impairm., avoid K -spar.diuret., poss.dos.adjustm.of anti-
                                             +
   ren.art.stenos.with singl.kidn., aort.stenos., concom. K  spar.diuret.,   diabet.agents, decr.Ca excret.lead.to poss.elev. ser.Ca lev., poss.incr.  syncope, hypoaesthes., paraesthes., vis.disturbs., tinnit., hypotens.,
                         +
   porphyr., Li ther., concom. aliskiren.  in cholesterol & trigylceride lev., diuret.induc.hyperuricaem.attenuat.,   dyspn., rhinit., vomit., dyspeps., alter.bowel habits, dry mouth, alopec.,
   Side effects: Freq: Vir.infects., neutropen., postur. dizzin., post.  adeq. contracept.for women of childbear.age,  purpura, skin discolorat., incr.sweat, prurit., rash, arthralg., myalg.,
   hypotens. Less freq: URTI, pharyngit., sinusit., rhinit., thrombocyto-  Drug interactions: Potent.of other antihypertens., reduc.lev.with   musc.cramps, back pain, micturit.disord., noctur., incr.urin.freq., impot.,
   pen., hypersens. incl.ser.sickn., hyperkalaem., insomn., decr. libido,   rifampic.& fluconazole, NSAID’s may reduc.antihypertens./diuret.&   gynaecomast., chest pain, asthen., pain, malaise, weight incr./decr.
   syncope, dizzin., headache, blurr. vis., vertigo, CF, poss.hypotens.in vol.  natriuret.eff., addit.hyperkalaem.eff.of K -spar.diuret./K  supplem./   V.rare: Leucopaen., thrombocytopaen., allerg. react., hyperglycaem.,
                                                       +
                                                 +
   deplet.pts., vasculit., cough, GI disords., angioed., skin reacts., back   K  salt substit.& other meds.caus. hyperkalaem., alcoh./barbit.& nar-  hyperton., periph. neuropathy, myocard.infarct., arrhythm., vasculit.,
                                 +
   pain, arthralg., myalg., rhabdomyolys., ren. insuff., ac.ren.fail., fatig.,   cot.potent. orthostat.hypotens., bld.gluc.conc.incr., cholestyramine/   cough., pancreatit., gastrit., gingiv.hyperplas., hepatit., jaund., hepat.
   asthen., oed. Freq. unknown: Hepatit., alopec.  colestipol reduc.hydrochlorothiaz. absorpt., corticoster.& ACTH inten-  enzyme elev., angioed., erythema multiforme, urticar. Atorvastatin:
   Warnings and special precautions: Safety & effic. in childr.& ado-  sif.electrol. deplet. partic. hypokalaem., beta 2-agon.enhanc.K  deplet.  Common: Allerg.react., insomn., hypoaesthes., paraesthes., dizzin.,
                                                         +
   lesc.bel.18 yrs.not est., discont. ther.if pregn.plann./confirm., adeq.   effs., respons.to sympathomimet.decr., block. of non-depolaris. neu-  headache, nausea, diarrh., abdom. pain, dyspeps., constip., flatul.,
   contracept. in women of childbear.potent., Na & vol. deplet. correct.  romusc.block.agents enhanc., reduc.Li clear.  prurit., rash, myalg., arthralg., back/chest pain, asthen. Uncom-
   bef.init.ther., where ren.funct. depend.on renin-angiotens.-aldost.  mon: Thrombocytopaen, hypo-/hyperglycaem., anorex., weight gain,
   syst.activ., bil. obstruct. disords., not recomm.in sev.hepat. impairm.,   ZOMEVEK, Sandoz [P/S]  periph. neuropathy, amnes., tinnit., vomit., alopec., urticar., impot.,
   monit.ser.K lev.esp.in elderly/ren. impairm., init.ther.in HF, ren.funct.  Valsartan.  malaise. Rare: Pancreatit., hepatit., cholestat. jaund., bullous rash.,
       +
                        S4 Pradaxa ® . 110 mg. Each capsule contains 110 mg of dabigatran etexilate base (as mesilate salt). Reg. No. 42/8.2/0131. S4 Pradaxa ® . 150 mg. Each capsule contains 150 mg of dabigatran
                        etexilate base (as mesilate salt). Reg. No. 45/8.2/0162. For full prescribing information refer to the professional information approved by the Regulatory Authority.
                        Applicant details: Ingelheim Pharmaceuticals (Pty) Ltd, 407 Pine Ave, Randburg. Tel: +27 (011) 348-2400. Cpy. Reg. No. 1966/008618/07. BI Ref. No. PC-ZA-100406. Expiry date: August 2021.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page152.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>
             </td>
             <td width="35%"><a href="page154.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page154.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
